1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
Articles 

Regeneron Pharmaceuticals Inc (REGN) EVP Finance CFO Robert E Landry Sold $2.6 million of Shares

June 10, 2020 | About:

EVP Finance CFO of Regeneron Pharmaceuticals Inc (30-Year Financial, Insider Trades) Robert E Landry (insider trades) sold 4,271 shares of REGN on 06/09/2020 at an average price of $608.01 a share. The total sale was $2.6 million.

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron Pharmaceuticals Inc has a market cap of $62.31 billion; its shares were traded at around $606.59 with a P/E ratio of 30.47 and P/S ratio of 8.72. Regeneron Pharmaceuticals Inc had annual average EBITDA growth of 26.80% over the past five years. GuruFocus has detected 1 severe warning sign with Regeneron Pharmaceuticals Inc. .

CEO Recent Trades:

  • President & CEO Leonard S Schleifer sold 150,922 shares of REGN stock on 05/12/2020 at the average price of $569.22. The price of the stock has increased by 6.57% since.

CFO Recent Trades:

  • EVP Finance CFO Robert E Landry sold 4,271 shares of REGN stock on 06/09/2020 at the average price of $608.01. The price of the stock has decreased by 0.23% since.

Directors and Officers Recent Trades:

  • Director Joseph L Goldstein sold 10,838 shares of REGN stock on 06/08/2020 at the average price of $592.95. The price of the stock has increased by 2.3% since.
  • Director Bonnie L Bassler sold 2,559 shares of REGN stock on 06/05/2020 at the average price of $600. The price of the stock has increased by 1.1% since.
  • Director Arthur F Ryan sold 100 shares of REGN stock on 06/01/2020 at the average price of $603.23. The price of the stock has increased by 0.56% since.
  • Director George L Sing sold 2,000 shares of REGN stock on 05/29/2020 at the average price of $587.76. The price of the stock has increased by 3.2% since.
  • 10% Owner Sanofi sold 22,821,451 shares of REGN stock on 05/29/2020 at the average price of $509.85. The price of the stock has increased by 18.97% since.

For the complete insider trading history of REGN, click here

.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)